Join to View Full Profile
1600 SW Archer RdGainesville, FL 32610
Phone+1 352-273-7832
Fax+1 352-273-7849
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1997
University of Vermont College of MedicineClass of 1994
Certifications & Licensure
FL State Medical License 2002 - 2028
TX State Medical License 2023 - 2025
DC State Medical License 2018 - 2022
MD State Medical License 1997 - 2002
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification FirstNet, Cerner Corporation, 2014
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and IQHealth, Cerner Corporation, 2014
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Corporation, 2014
Clinical Trials
- Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) Start of enrollment: 2005 Apr 01
- Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer Start of enrollment: 2004 Dec 01
- Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2005 Jul 01
Publications & Presentations
PubMed
- Severe toxicity following genotype-guided reduced 5-FU dose in a heterozygous DPYD c.2846A>T carrier with stage III anal carcinoma: A case report.Madeline L Norris, David L DeRemer, Julio D Duarte, George P Kim, Thomas J George
Cancer Chemotherapy and Pharmacology. 2025-11-21 - 1 citationsSelect updates from ASCO and ESMO 2024 for gastrointestinal cancer care.Tim Jang, George P Kim, Thomas J George
The Oncologist. 2025-02-06 - 4 citationsA phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.Sonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, Rui Qin, Jonathan Strosberg
Endocrine-Related Cancer. 2023-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
